ea0092ps1-02-03 | Graves’ Disease | ETA2023
Lindholm Lars
, Sjolin Gabriel
, Jonsson Annika
, Wallin Goran
, Filipsson Nystrom Helena
Background: Guidelines in healthcare shall be evidence-based, satisfy patients needs and improve patients outcomes. We aimed to estimate incremental costs after the introduction of a national guideline for Graves disease in Sweden adding the Graves Recurrent Events After Therapy (GREAT) score with genetic determinants to predict recurrence, a thyroid nurse, calcium-D-vitamin treatment preoperatively, and thyroid stimulating immunoglobulins.<p class=...